This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Thomas Kraft, Ph.D
Senior Principal Scientist at Roche
Speaker

Profile

I am a Senior Principal Scientist at Roche in ADME, Pharmaceutical Sciences within Pharma Research and Early Development. I received my PhD in Biochemistry at Washington University, School of Medicine in St. Louis, MO and completed postdoctoral training at Roche, Large Molecule Research focusing on elucidating the antibody structure - PK relationship, before starting my current position in 2018. I am leading the large molecule ADME and in vitro DMPK efforts at Roche together with several scientists where our work focuses on antibody DMPK, specifically developing novel in vitro assays and understanding the biological processes that govern the absorption, disposition, metabolism and clearance of therapeutic antibodies. We also work towards the integration of in vitro and in silico readouts with mathematical models to ultimately predict antibody PK properties in humans without the use of animals.

Agenda Sessions

  • Structure-PK Relationships in Complex Antibodies: Guiding Engineering for Optimal Clearance

    16:25